Finch Therapeutics ^Corporations

Finch Therapeutics is a microbiome development company that is focused on serving patients with serious unmet medical needs. They use machine learning algorithms to reverse engineer successful fecal transplantations and other clinical datasets in order to identify the microbes that drive positive responses in patients. By leveraging clinical data, Finch Therapeutics is able to develop cocktails of microbes that have already demonstrated safety and efficacy in humans, reducing translational risk. They have a strong intellectual property estate and have made significant advancements in the field of microbiome therapeutics. Recently, they announced a $90 million financing to advance their pipeline of investigational oral microbiome drugs.